Turning Point Therapeutic...

NASDAQ: TPTX · Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-123.09M -74.44M -78.45M -66.33M -56.27M -35.5M
Depreciation & Amortization
1.32M 1.25M 1.27M 1.21M 850K 633K
Stock-Based Compensation
17.31M 15.09M 14.19M 13.79M 13.29M 17.28M
Other Working Capital
-1.64M -3.08M 5.07M 12.04M -1.7M -1.03M
Other Non-Cash Items
530K 893K 1.24M 1.32M 1.37M 1.4M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.37M -1.12M 7.59M 8.33M -1.63M 511K
Operating Cash Flow
-105.3M -58.33M -54.15M -41.66M -42.39M -15.68M
Capital Expenditures
-1.53M -447K -387K -1.17M -731K -143K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-29.75M -134.78M -47.89M -135.58M -95.11M -160.65M
Sales Maturities Of Investments
108.22M 74.82M 123.5M 154.19M 87.57M 81.86M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
76.94M -60.41M 75.22M 17.44M -8.27M -78.93M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-396K 396K 2.6M 2.38M 9.34M 9.68M
Financial Cash Flow
8.97M 396K 2.6M 2.38M 9.34M 9.68M
Net Cash Flow
-19.39M -118.35M 23.68M -21.84M -41.24M -84.93M
Free Cash Flow
-106.83M -58.78M -54.54M -42.83M -43.12M -15.82M